Faculty of Computer Science, Dalhousie University, Halifax, NS, Canada.
Emagix, Inc., Halifax, NS, Canada.
Eye (Lond). 2023 May;37(7):1293-1301. doi: 10.1038/s41433-022-02120-4. Epub 2022 May 28.
To present a fluorescein angiography (FA)‒based computer algorithm for quantifying retinal blood flow, perfusion, and permeability, in patients with diabetic retinopathy (DR). Secondary objectives were to quantitatively assess treatment efficacy following panretinal photocoagulation (PRP) and define thresholds for pathology based on a new retinovascular function (RVF) score for quantifying disease severity.
FA images of 65 subjects (58 patients and 7 healthy volunteers) were included. Dye intensity kinetics were derived using pixel-wise linear regression as a measure of retinal blood flow, perfusion, and permeability. Maps corresponding to each measure were then generated for each subject and segmented further using an ETDRS grid. Non-parametric statistical analyses were performed between all ETDRS subfields. For 16 patients, the effect of PRP was measured using the same parameters, and an amalgam of RVF was used to create an RVF index. For ten post-treatment patients, the change in FA-derived data was compared to the macular thickness measured using optical coherence tomography.
Compared to healthy controls, patients had significantly lower retinal and regional perfusion and flow, as well as higher retinal permeability (p < 0.05). Moreover, retinal flow was inversely correlated with permeability (R = -0.41; p < 0.0001). PRP significantly reduced retinal permeability (p < 0.05). The earliest marker of DR was reduced retinal blood flow, followed by increased permeability. FA-based RVF index was a more sensitive indicator of treatment efficacy than macular thickness.
Our algorithm can be used to quantify retinovascular function, providing an earlier diagnosis and an objective characterisation of disease state, disease progression, and response to treatment.
提出一种基于荧光素血管造影(FA)的计算机算法,用于量化糖尿病视网膜病变(DR)患者的视网膜血流、灌注和通透性。次要目的是定量评估全视网膜光凝(PRP)后的治疗效果,并基于新的视网膜血管功能(RVF)评分定义病理学阈值,以量化疾病严重程度。
纳入了 65 名受试者(58 名患者和 7 名健康志愿者)的 FA 图像。使用逐像素线性回归来推导染料强度动力学,作为视网膜血流、灌注和通透性的衡量标准。然后为每个受试者生成相应的每个测量值的图谱,并使用 ETDRS 网格进一步进行分割。对所有 ETDRS 亚区进行了非参数统计分析。对于 16 名患者,使用相同的参数测量了 PRP 的效果,并使用 RVF 组合创建了 RVF 指数。对于 10 名治疗后的患者,比较了 FA 衍生数据的变化与光学相干断层扫描测量的黄斑厚度。
与健康对照组相比,患者的视网膜和区域灌注和血流明显降低,而视网膜通透性较高(p<0.05)。此外,视网膜血流与通透性呈负相关(R=-0.41;p<0.0001)。PRP 可显著降低视网膜通透性(p<0.05)。DR 的最早标志物是视网膜血流减少,其次是通透性增加。基于 FA 的 RVF 指数是治疗效果的更敏感指标,优于黄斑厚度。
我们的算法可用于量化视网膜血管功能,提供更早的诊断和对疾病状态、疾病进展和治疗反应的客观描述。